EVEON accelerates its developments and expands its range of medical devices.

EVEON celebrated its 10th anniversary and is ranked by Forbes as the 3rd most inventive French company in the medical technologies category.

The presentation of the DIPSA project, needle-free piezoelectric injection device, to the Auvergne Rhone Alpes region, as part of the call for R&D booster projects, received a favourable opinion in March 2019. The project was launched on Tuesday, April 15, 2019, at Cedrat Technologies (CTEC), project coordinator, with EVEON, as industrial partner, and the Grenoble Rheology and Processes Laboratory (LRP). 

EVEON, as part of a partnership with a pharmaceutical laboratory, has delivered, on schedule, the first functional prototypes based on the innovative medical device Intuity® Ject.

EVEON is announcing that it has forged a partnership with a pharmaceutical laboratory for a development based on the innovative Intuity® Ject medical device, recipient of a 2017 Pharmapack Award.

EVEON and six French companies have sealed a unique partnership called JBT HubUp a unique solution for developing innovative medical devices.

A EVEON was awarded the special prize Ease of use and Patient compliance in the Best Innovation Exhibitor category at Pharmapack Europe 2017 for its Intuity® Ject device.

EVEON announces the release of its new prototype, which reconstitutes lyophilised drugs in just two steps, with no handling or contact with the product.

STMicroelectronics Grenoble and EVEON have signed a partnership agreement aimed at supplying components to be used in new generation medical devices developed by EVEON that will respond to the growing demand for injectable biological treatments.